These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9021107)

  • 1. Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects.
    Busatto GF; Pilowsky LS; Costa DC; Mertens J; Terriere D; Ell PJ; Mulligan R; Travis MJ; Leysen JE; Lui D; Gacinovic S; Waddington W; Lingford-Hughes A; Kerwin RW
    Eur J Nucl Med; 1997 Feb; 24(2):119-24. PubMed ID: 9021107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects.
    Baeken C; D'haenen H; Flamen P; Mertens J; Terriere D; Chavatte K; Boumon R; Bossuyt A
    Eur J Nucl Med; 1998 Dec; 25(12):1617-22. PubMed ID: 9871092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: part 2--ketanserin displacement.
    Catafau AM; Danus M; Bullich S; Nucci G; Llop J; Abanades S; Cunningham VJ; Eersels JL; Pavia J; Farre M
    J Nucl Med; 2006 Jun; 47(6):929-37. PubMed ID: 16741301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and displacement studies of the selective 5-HT2A receptor antagonist 123I-5-I-R91150 in the normal dog.
    Peremans K; Audenaert K; Jacobs F; Dumont F; De Vos F; Van De Wiele C; Vandecapelle M; Van Bree H; Verschooten F; Slegers G; Mertens J; Dierckx R
    Nucl Med Commun; 2002 Oct; 23(10):1019-27. PubMed ID: 12352602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors.
    Abi-Dargham A; Zea-Ponce Y; Terriere D; al-Tikriti M; Baldwin RM; Hoffer P; Charney D; Leysen JE; Laruelle M; Mertens J; Innis RB
    Eur J Pharmacol; 1997 Mar; 321(3):285-93. PubMed ID: 9085039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
    Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
    J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice.
    Samnick S; Remy N; Ametamey S; Bader JB; Brandau W; Kirsch CM
    Life Sci; 1998; 63(22):2001-13. PubMed ID: 9839544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients.
    Audenaert K; Van Laere K; Dumont F; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    Eur J Nucl Med; 2001 Feb; 28(2):175-82. PubMed ID: 11303887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2A receptors in the feline brain: 123I-5-I-R91150 kinetics and the influence of ketamine measured with micro-SPECT.
    Waelbers T; Polis I; Vermeire S; Dobbeleir A; Eersels J; De Spiegeleer B; Audenaert K; Slegers G; Peremans K
    J Nucl Med; 2013 Aug; 54(8):1428-33. PubMed ID: 23819924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional binding index of the radiolabeled selective 5-HT2A antagonist 123I-5-I-R91150 in the normal canine brain imaged with single photon emission computed tomography.
    Peremans K; Audenaert K; Coopman F; Jacobs F; Dumont F; Slegers G; Verschooten F; van Bree H; Mertens J; Dierckx R
    Vet Radiol Ultrasound; 2003; 44(3):344-51. PubMed ID: 12816380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo 5-HT2A receptor blockade by quetiapine: an R91150 single photon emission tomography study.
    Jones HM; Travis MJ; Mulligan R; Bressan RA; Visvikis D; Gacinovic S; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2001 Aug; 157(1):60-6. PubMed ID: 11512044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
    Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
    Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150.
    Peremans K; Audenaert K; Coopman F; Blanckaert P; Jacobs F; Otte A; Verschooten F; van Bree H; van Heeringen K; Mertens J; Slegers G; Dierckx R
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1538-46. PubMed ID: 14579095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150.
    Travis MJ; Busatto GF; Pilowsky LS; Mulligan R; Acton PD; Gacinovic S; Mertens J; Terrière D; Costa DC; Ell PJ; Kerwin RW
    Br J Psychiatry; 1998 Sep; 173():236-41. PubMed ID: 9926100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.
    Pike VW; Halldin C; Nobuhara K; Hiltunen J; Mulligan RS; Swahn CG; Karlsson P; Olsson H; Hume SP; Hirani E; Whalley J; Pilowsky LS; Larsson S; Schnell PO; Ell PJ; Farde L
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1520-8. PubMed ID: 14579092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
    Audenaert K; Van Laere K; Dumont F; Vervaet M; Goethals I; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    J Nucl Med; 2003 Feb; 44(2):163-9. PubMed ID: 12571204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the brain 5-HT2A receptor binding index in dogs with anxiety disorders, measured with 123I-5I-R91150 and SPECT.
    Vermeire ST; Audenaert KR; Dobbeleir AA; De Meester RH; De Vos FJ; Peremans KY
    J Nucl Med; 2009 Feb; 50(2):284-9. PubMed ID: 19164223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-animal single-photon emission computed tomographic imaging of the brain serotoninergic systems in wild-type and mdr1a knockout rats.
    Dumas N; Moulin-Sallanon M; Ginovart N; Tournier BB; Suzanne P; Cailly T; Fabis F; Rault S; Charnay Y; Millet P
    Mol Imaging; 2014; 13():. PubMed ID: 24622810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography.
    Peremans K; Audenaert K; Blanckaert P; Jacobs F; Coopman F; Verschooten F; Van Bree H; Van Heeringen C; Mertens J; Slegers G; Dierckx R
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1393-404. PubMed ID: 12502029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Quantification of 5-HT2A Brain Receptors in Mdr1a KO Rats with 123I-R91150 Single-Photon Emission Computed Tomography.
    Dumas N; Moulin-Sallanon M; Fender P; Tournier BB; Ginovart N; Charnay Y; Millet P
    Mol Imaging; 2015; 14():. PubMed ID: 26105563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.